Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Denali Therapeutics
(D2NL34.SA) Q4 2024
Earnings
D2NL34.SA
Nov 6
Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-4.24
-3.95
-3.67
-3.38
Details
Expected EPS
-3.3768578376000002
Actual EPS
-3.575124
Surprise EPS
-0.2
Surprise Percent
-5.87%
Description
Denali Therapeutics (D2NL34.SA) has reported earnings of -3.575124 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login